From the analyst's couch: Next-generation antibodies.

Evans, James B; Syed, Basharut A

Evans, James B; Syed, Basharut A.

Affiliation

Evans JB; Visiongain, BSG HOUSE, 230 City Road, London, EC1V 2QY, UK.
Syed BA; IMS Health, 210 Pentonville Road, London N1 9JY, UK.

Nat Rev Drug Discov ; 13(6): 413-4, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24722461

Subject(s)

Antibodies/therapeutic use; Clinical Trials as Topic; Drug Design; Drugs, Investigational/therapeutic use; Antibodies/chemistry; Antibodies/economics; Antibodies/metabolism; Antibodies, Monoclonal/chemistry; Antibodies, Monoclonal/economics; Antibodies, Monoclonal/metabolism; Antibodies, Monoclonal/therapeutic use; Antibody Specificity; Antineoplastic Agents/chemistry; Antineoplastic Agents/economics; Antineoplastic Agents/metabolism; Antineoplastic Agents/therapeutic use; Drug Costs; Drugs, Investigational/chemistry; Drugs, Investigational/economics; Drugs, Investigational/metabolism; Humans; Immunotoxins/chemistry; Immunotoxins/economics; Immunotoxins/metabolism; Immunotoxins/therapeutic use; Ligands; Neoplasms/drug therapy; Neoplasms/economics; Protein Engineering

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Drugs, Investigational / Clinical Trials as Topic / Antibodies Limits: Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google